PMI Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Picard Medical, Inc.

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Picard Medical, Inc. (PMI) securities between September 2, 2025, and October 31, 2025, due to allegations of a fraudulent stock promotion scheme [1][2]. Group 1: Allegations Against Picard Medical - The complaint alleges that Picard Medical was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [2]. - It is claimed that insiders and/or affiliates utilized offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - The company's public statements and risk disclosures reportedly failed to mention the false rumors and artificial trading activity that influenced the stock price [2]. Group 2: Stock Price Impact - On October 24, 2025, Picard's stock price experienced a significant crash of 70%, dropping to $3.99 per share, and has since continued to decline to approximately $2.00 per share [3]. Group 3: Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must file their papers with the court by April 3, 2026, although participation is not required to be eligible for recovery [4]. - Individuals can choose to remain absent class members if they do not wish to take action [4]. Group 4: Robbins LLP Overview - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].